Evidence map›Paper›PMID 34142663›Full record

ArticleClinical and translational gastroenterology2021

Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.

Archita P Desai, Marion Greene, Lauren D Nephew, Eric S Orman, Marwan Ghabril, Naga Chalasani, Nir Menachemi

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Archita P DesaiDepartment of Gastroenterology and Hepatology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Marion GreeneDepartment of Health Policy and Management, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.
Lauren D NephewDepartment of Gastroenterology and Hepatology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Eric S OrmanDepartment of Gastroenterology and Hepatology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Marwan GhabrilDepartment of Gastroenterology and Hepatology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Naga ChalasaniDepartment of Gastroenterology and Hepatology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Nir MenachemiDepartment of Health Policy and Management, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.
Indiana University – Purdue University Indianapolis · US

Funding

The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in CirrhosisK23DK123408 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DESAI, ARCHITA P. · 2020 to 2024
$903k
NIDDK NIH HHS K23 DK123408NIDDK NIH HHS L30 DK122508
6 · The paper itself

Abstract

introductionChronic liver diseases (CLDs) and substance use disorders (SUDs) are increasingly prevalent and often coexist. Contemporary studies describing the characteristics and hospitalization trends of those with comorbid CLD-SUD are lacking. We aimed to characterize a population-based cohort with comorbid CLD-SUD and describe trends in these hospitalizations over time by individual-level characteristics.

methodsWe performed a cross-sectional analysis of the National Inpatient Sample from 2005 through 2017. Diagnosis codes were used to identify adult hospitalizations with CLD, SUD, or both. Bivariate and multivariate analyses were used to make comparisons between diagnosis categories. Unadjusted and age-adjusted trends in these hospitalizations were described over time.

resultsOf 401,867,749 adult hospital discharges, 3.2% had CLD-only and 1.7% had comorbid CLD-SUD. Compared with CLD-only, comorbid CLD-SUD hospitalizations resulted in higher inpatient mortality (3.1% vs 2.4%, P < 0.001) and were associated with younger age, male sex, Native American race, and urban and Western US location. Over time, comorbid hospitalizations grew 34%, and the demographics shifted with larger increases in hospitalization rates seen in younger individuals, women, Native Americans, and those publicly insured. In comorbid hospitalizations, alcoholic SUD and CLD decreased, but drug SUDs and nonalcoholic fatty liver diseases are fast-growing contributors. DISCUSSION: In this comprehensive analysis of US hospitalizations, comorbid CLD-SUD hospitalizations are increasing over time and lead to higher inpatient mortality than CLD alone. We further characterize the changing demographics of these hospitalizations, providing a contemporary yet inclusive look at comorbid CLD-SUD hospitalizations. These data can guide interventions needed to improve the poor outcomes suffered by this growing population.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionChronic DiseaseComorbidityCross-Sectional StudiesDatabases, FactualFemaleHospitalizationHumansLiver DiseasesLogistic ModelsMaleMiddle Aged

Identifiers

PMID34142663
PMCPMC8216677
OpenAlexW3171408925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.